Oral communications and exchanges (Session 29-32)

CO-29-1: Amadé SAWADOGO:
Evaluation of potential risks related to the dissemination of genetically modified Metarhizium for vector control by obtaining expert opinions

CO-30-1: André THIOMBIANO:
Evaluation of antimicrobial prescription in dermatological conditions in the Nanoro health district in 2023, Burkina Faso

CO-31-1: Assétou
NANA/SANKARA: Phytochemistry and
antioxidant activity of the
non-volatile compounds of
Cymbopogon nardus (L.) Rendl

CO-32-1: Siébou HIEN:
Factors associated with discharge against medical advice in patients with renal insufficiency at the Regional University Hospital Center of Ouahigouya

CO-29-2: Wend Denda
Welcome NANA:
Persistence of intestinal parasitic infections in urban areas of Burkina Faso

CO-30-2: W.O. Benjamin KABORÉ: SARS-CoV-2 Sentinel Surveillance Among People With Influenza-Like Illness (ILI) and Severe Acute Respiratory Infections (SARI) in Burkina Faso

CO-31-2: Sylvain ILBOUDO: Acute and Subchronic Toxicity Studies of “ANOL”, a Phytomedicine Intended for Hypertension Care in Burkina Fa

CO-32-2: Adama TIAMA:
Characterization of Injuries During a Sports Season Among Elite Football Players in Burkina Faso: Case Study of the 2019-2020 Season

CO-29-3: Delwendé Florence OUEDRAOGO: Diagnosis of asymptomatic carriage of Plasmodium falciparum by optical microscopy and quantitative PCR before, during, and after the rainy season in the health district of Nanoro, Burkina Faso

CO-30-3: Namwin Siourimè
SOMDA:
Molecular characterization of Methicillin-resistant Staphylococcus aureus isolated in ready-to-eat food sold in supermarkets in Bobo-Dioulasso: case of charcuterie products

CO-31-3: Oumarou MAMAN 
NOURA:
Phytochemical profile, 
antioxidant and contractile activity 
of plants used by parturient to 
manage childbirth in Niger

CO-32-3: Mathieu MILLOGO:
Lip lesions caused by intentional human bite

CO-29-4: Sabere Oliver Gilles 
YEMIEN:
Evaluating the Role of 
HPPD in Blood Meal Digestion 
and Genetic Control of 
Anopheles funestus

CO-30-4: Dissinviel Stéphane KPODA:
Genetic characterization 
of extended-spectrum β￾lactamase-producing Escherichia 
coli groups A, B1, B2, C and D 
isolated from food and humans in 
Ouagadougou, Burkina Faso
 

CO-31-4: Relwendé Justin OUEDRAOGO:
Fractions of alkaloids and isopteropodine derived from Mitragyna inermis may be potential anesthetics

CO-32-4: Michel MOUKORO:
Evaluation of the Analytical Performance of Indiko® and Indiko Plus® Automates in the Biochemistry Section of the Clinical Biology Laboratory at the MURAZ Center

CO-29-5: Nabasnogo Odette 
ZONGO:
Exploring novel functional genetics tools in 
Anopheles funestus: Evaluating the zpg promoter on a doublesex gene drive system

O-30-5: Maïmounata Rufaïda
YOUGBARE:
Characterization of CTX-M group 1 and OXA genes in enteropathogenic and non-enteropathogenic Escherichia coli strains producing extended-spectrum beta-lactamases (ESBL) isolated from children under two years old at the Protestant Hospital Schiphra in Ouagadougou

CO-31-5: Oumarou OUEDRAOGO:
Integration of new information and communication technologies in the promotion of traditional medicine in Burkina Faso

CO-32-5: Thierry Boris Wend-Yam YAMEOGO:
From cardiomyocyte to pixel: numerical modeling of the cardiovascular system

CO-31-6: Salfo OUÉDRAOGO:
Quality control and stability study of raw materials and finished products based on the powders of Feretia apodanthera del. (Rubiaceae)

CO-32-6: Julien DEMBÉLÉ: Strategy for developing effective intracellular-targeting protein therapy